Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation

Fig. 1

a Kaplan-Meier survival curves comparing transplant free survival in patients taking and not taking non-selective beta blocker (NSBB) at the time of initial liver transplant evaluation (analysis restricted to 365 days after initial evaluation). b Kaplan-Meier survival curves comparing the incidence of acute kidney injury during follow up in patients taking and not taking non-selective beta blocker (NSBB) (analysis restricted to 365 days after initial evaluation)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us